Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2021-06-02 Purchase |
2021-06-04 4:06 pm |
Vallon Pharmaceuticals Inc. | VLON | Kelly Leanne M. Chief Financial Officer |
6,250 | $4.028 | $25,175 | 6,250 (Direct) |
View |
| 2021-05-25 Purchase |
2021-05-27 8:37 pm |
Vallon Pharmaceuticals Inc. | VLON | Payne Joseph E Director |
17,500 | $4.1026 | $71,795 | 861,250 (Indirect Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2025-01-23 Option Award |
2025-01-24 5:58 pm |
2025-01-23 2035-01-23 |
GRI Bio Inc. | GRI | Kelly Leanne Chief Financial Officer |
43,319 | $0.6857 | 43,319 (Direct) |
View |
| 2025-01-23 Option Award |
2025-01-24 5:58 pm |
2025-01-23 2035-01-23 |
GRI Bio Inc. | GRI | Chaturvedi Vipin Chief Scientific Officer |
43,319 | $0.6857 | 43,319 (Direct) |
View |
| 2025-01-23 Option Award |
2025-01-24 5:58 pm |
2025-01-23 2035-01-23 |
GRI Bio Inc. | GRI | Hertz Walter Marc Chief Executive Officer |
129,730 | $0.6857 | 129,730 (Direct) |
View |
| 2025-01-23 Option Award |
2025-01-24 5:57 pm |
2025-01-23 2035-01-23 |
GRI Bio Inc. | GRI | SIMPSON CAMILLA V Director |
30,297 | $0.6857 | 30,297 (Direct) |
View |
| 2025-01-23 Option Award |
2025-01-24 5:57 pm |
2025-01-23 2035-01-23 |
GRI Bio Inc. | GRI | Baker David Charles Director |
30,297 | $0.6857 | 30,297 (Direct) |
View |
| 2025-01-23 Option Award |
2025-01-24 5:57 pm |
2025-01-23 2035-01-23 |
GRI Bio Inc. | GRI | Szekeres David Leslie Director |
51,937 | $0.6857 | 51,937 (Direct) |
View |
| 2025-01-23 Option Award |
2025-01-24 5:57 pm |
2025-01-23 2035-01-23 |
GRI Bio Inc. | GRI | Rongen Roelof Director |
30,297 | $0.6857 | 30,297 (Direct) |
View |
| 2023-09-22 Option Award |
2023-09-26 4:08 pm |
N/A 2033-09-22 |
GRI BIO Inc. | GRI | Kelly Leanne Chief Financial Officer |
83,333 | $1.52 | 83,333 (Direct) |
View |
| 2023-08-10 Option Award |
2023-08-14 4:10 pm |
N/A 2033-08-10 |
GRI BIO Inc. | GRI | Szekeres David Leslie Director |
34,483 | $2.9 | 34,483 (Direct) |
View |
| 2023-08-10 Option Award |
2023-08-14 4:07 pm |
N/A 2033-08-10 |
GRI BIO Inc. | GRI | SIMPSON CAMILLA V Director |
34,483 | $2.9 | 34,483 (Direct) |
View |
| 2023-08-10 Option Award |
2023-08-14 4:07 pm |
N/A 2033-08-10 |
GRI BIO Inc. | GRI | Rongen Roelof Director |
34,483 | $2.9 | 34,483 (Direct) |
View |
| 2023-08-10 Option Award |
2023-08-14 4:06 pm |
N/A 2033-08-10 |
GRI BIO Inc. | GRI | Baker David Charles Director |
34,483 | $2.9 | 34,483 (Direct) |
View |
| 2023-04-21 Option Award |
2023-04-24 6:30 pm |
N/A N/A |
GRI BIO Inc. | GRI | Hertz Walter Marc Chief Executive Officer 10% Owner |
385,510 | $0 | 385,510 (Direct) |
View |
| 2023-04-21 Option Award |
2023-04-24 6:29 pm |
N/A N/A |
GRI BIO Inc. | GRI | Agro Albert Chief Medical Officer |
172,189 | $0 | 172,189 (Direct) |
View |
| 2023-04-21 Option Award |
2023-04-24 6:29 pm |
N/A N/A |
GRI BIO Inc. | GRI | Chaturvedi Vipin Chief Scientific Officer |
172,189 | $0 | 172,189 (Direct) |
View |
| 2022-12-13 Other |
2022-12-15 4:26 pm |
N/A N/A |
Vallon Pharmaceuticals Inc. | VLON | Thorell Marella Director |
28,517 | $0 | 38,023 (Direct) |
View |
| 2022-07-01 Option Award |
2022-07-06 2:03 pm |
N/A N/A |
Vallon Pharmaceuticals Inc. | VLON | Thorell Marella Director |
38,023 | $0 | 38,023 (Direct) |
View |
| 2022-06-09 Option Award |
2022-06-10 1:32 pm |
N/A 2032-06-09 |
Vallon Pharmaceuticals Inc. | VLON | Ammer Richard Director |
7,500 | $0 | 7,500 (Direct) |
View |
| 2022-06-09 Option Award |
2022-06-10 1:32 pm |
N/A 2032-06-09 |
Vallon Pharmaceuticals Inc. | VLON | Payne Joseph E Director |
7,500 | $0 | 7,500 (Direct) |
View |
| 2022-06-09 Option Award |
2022-06-10 1:31 pm |
N/A 2032-06-09 |
Vallon Pharmaceuticals Inc. | VLON | Thorell Marella Director |
7,500 | $0 | 7,500 (Direct) |
View |
| 2022-02-23 Option Award |
2022-03-09 5:02 pm |
N/A 2032-02-23 |
Vallon Pharmaceuticals Inc. | VLON | Chhabra Meenu Director |
15,000 | $7.67 | 15,000 (Direct) |
View |
| 2022-02-15 Option Award |
2022-03-01 5:04 pm |
N/A 2032-02-15 |
Vallon Pharmaceuticals Inc. | VLON | Baker David Charles Chief Executive Officer |
61,000 | $5.63 | 61,000 (Direct) |
View |
| 2022-02-15 Option Award |
2022-03-01 5:03 pm |
N/A 2032-02-15 |
Vallon Pharmaceuticals Inc. | VLON | Kelly Leanne M. Chief Financial Officer |
50,000 | $5.63 | 50,000 (Direct) |
View |
| 2021-05-14 Option Award |
2021-05-18 4:09 pm |
N/A 2031-05-14 |
Vallon Pharmaceuticals Inc. | VLON | Payne Joseph E Director |
29,286 | $0 | 29,286 (Direct) |
View |
| 2021-05-14 Option Award |
2021-05-18 4:08 pm |
N/A 2031-05-14 |
Vallon Pharmaceuticals Inc. | VLON | Ammer Richard Director |
25,204 | $0 | 25,204 (Direct) |
View |
| 2021-05-14 Option Award |
2021-05-18 4:08 pm |
N/A 2031-05-14 |
Vallon Pharmaceuticals Inc. | VLON | Levi Ofir Director |
45,000 | $0 | 45,000 (Direct) |
View |
| 2021-05-14 Option Award |
2021-05-18 4:07 pm |
N/A 2031-05-14 |
Vallon Pharmaceuticals Inc. | VLON | Kelly Leanne M. Chief Financial Officer |
70,000 | $0 | 70,000 (Direct) |
View |
| 2021-05-14 Option Award |
2021-05-18 4:06 pm |
N/A 2031-05-14 |
Vallon Pharmaceuticals Inc. | VLON | Toren Penny SVP, Regul Affairs & Prog Mgmt |
25,000 | $0 | 25,000 (Direct) |
View |
| 2021-05-14 Option Award |
2021-05-18 4:06 pm |
N/A 2031-05-14 |
Vallon Pharmaceuticals Inc. | VLON | Baker David Charles Chief Executive Officer |
100,000 | $0 | 100,000 (Direct) |
View |
| 2021-02-12 Other |
2021-02-12 6:02 pm |
N/A N/A |
Vallon Pharmaceuticals Inc. | VLON | Ammer Richard Director |
47,063 | $6.4 | 94,126 (Indirect) |
View |